BioCentury | Aug 8, 2018
Distillery Therapeutics

Cancer

INDICATION: Lung cancer Cell culture and mouse studies suggest activating PP2A could help treat KRAS-mutant lung cancer. In two human KRAS-mutant lung cancer lines, a previously reported tricyclic sulfonamide-based PP2A activator plus the MEK inhibitor...
BioCentury | Aug 18, 2016
Distillery Techniques

Techniques: Branched-chain amino acids from gut microbes as markers of insulin resistance

Biomarkers TECHNOLOGY: Tissue markers Levels of branched-chain amino acids (BCAAs) produced by the gut bacteria Prevotella copri and Bacteroides vulgatus could be useful for diagnosing insulin resistance. In patients, insulin resistance scores and a diagnosis...
Items per page:
1 - 2 of 2
BioCentury | Aug 8, 2018
Distillery Therapeutics

Cancer

INDICATION: Lung cancer Cell culture and mouse studies suggest activating PP2A could help treat KRAS-mutant lung cancer. In two human KRAS-mutant lung cancer lines, a previously reported tricyclic sulfonamide-based PP2A activator plus the MEK inhibitor...
BioCentury | Aug 18, 2016
Distillery Techniques

Techniques: Branched-chain amino acids from gut microbes as markers of insulin resistance

Biomarkers TECHNOLOGY: Tissue markers Levels of branched-chain amino acids (BCAAs) produced by the gut bacteria Prevotella copri and Bacteroides vulgatus could be useful for diagnosing insulin resistance. In patients, insulin resistance scores and a diagnosis...
Items per page:
1 - 2 of 2